Hulu's highly anticipated The Handmaid's Tale spinoff The Testaments is in the works - but what is there to know about the ...
Gilead Sciences bought nearly 950,000 more shares of antiviral-therapeutics developer Assembly as part of an amended ...
Gilead and Terray Will Leverage Terray’s tNova ... have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets.
The colorful picture book is helping parents of young children deal with the difficult journey that follows a breast cancer ...
accessing novel technologies is critical to advancing our pipeline,” said Flavius Martin, MD, Executive Vice President, Research, Gilead Sciences. “With Gilead’s ongoing focus on innovating ...
-- Gilead and Terray Will Leverage Terray’s tNova Drug Discovery Platform to Identify Small Molecule Therapeutics Against Targets of Interest -- -- Gilead Has Exclusive Option to Develop and ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Terray Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule ...